Block Listing Return

Summary by AI ^BETAClose X

ECO Animal Health Group plc has submitted a block listing return detailing its Executive and Unapproved Share Option Schemes. The company originally listed 1,500,000 ordinary shares on 20 July 2017. Between 12 August 2025 and 12 February 2026, no new securities were issued or allotted under these schemes, leaving a balance of 375,505 unallotted securities. The block scheme itself was not increased during this period.

Disclaimer*

Eco Animal Health Group PLC

05 March 2026

ECO Animal Health Group plc

("ECO" or the "Company")

Block Listing Return

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, today makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

Name of applicant:		ECO Animal Health Group plc
Name of scheme:		Executive Share Option Scheme and Unapproved Share Option Scheme
Number and class of securities originally listed and the date of admission:		1,500,000 ordinary shares of 5 pence each on 20 July 2017
Period of return:	From:	12 August 2025	To:	12 February 2026
Balance of unallotted securities under scheme(s) from previous return:		375,505
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less: Number of securities issued/allotted under scheme(s) during period:		0
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		375,505

-Ends-

Contacts

ECO Animal Health Group plc

David Hallas (Chief Executive Officer)

Christopher Wilks (Chief Financial Officer)

020 8447 8899

ICR Healthcare (Financial PR)

Mary-Jane Elliott

Jessica Hodgson

020 3709 5700

Singer Capital Markets (Nominated Adviser & Joint Broker)

Philip Davies

Jalini Kalaravy

Samed Ethemi

020 7496 3000

Panmure Liberum (Joint Broker)

Emma Earl

Will Goode

Mark Rogers

Rupert Dearden

020 3100 2000

Equity Development

Hannah Crowe

Matt Evans

020 7065 2692

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin^® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Click here for more information: https://ecoanimalhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END